Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Not with all the potential to make a lot of money."
New investors beware, the above quote tis likened to an old refrain by foisters of this board.
Look at their(ipix) history, and compare to the chart/share price.
Sounds as though you've done quite well with ipix over the years with its ever declining share price.
'Next PR, IPIX signs monster deal...Leo melts snowflakes!!!!"
Agree. When he passes gas, yet again.
In hindsight, when comparing his involvement, or association, with publicly traded companies he may be arrested as a primary source of global warming.
imho
"If you haven't noticed, we have doubled from the low. Nothing wrong with taking some profits or riding free."
Talk about a weak minded argument to invest. Guess why that's why the flippers(shorters) are content.
Potential new investor's, stay away based upon the quote above lest you're content with the sp going down, down, down. Look at the long term chart.
""That dream is still alive for many of us,..."
Since the company has been asleep for 5 years, this must be some kind of dream.""
The heal clickers dream.
Get r done Dot!
My responses in bold type.
"In Leo's last PR he stated the overall GI market was expected to grow to $48B in 2022.
When did he state the above, and what is the market currently generating revenue wise?
The top selling drugs (Humira, Stelara, Remicade) in this market are immuno-suppressant, injectable biologics with side effects that include infections, cancer and death.
If Brilacidin is proven to be a safer, less toxic, more effective, orally administered drug (the evidence is growing) then YES, I think Brilacidin will ultimately gain 31% ($15B) or more of the GI market.
Sounds like one big IF coupled with a few maybe's. After all, as many board experts have noted, bio techs are risky.
Message in reply to:
Any chance of this being a $15 Billion performer ?"
I doubt it. The Captain of this ship is more sea sick than Columbus was when he thought he landed in India,in 1492, and was greeted by the Indians. This Captain is on a solo voyage, with three vessels secured by the same lines. One pilot, three ships, not good.
"The flipside analysis would be that he wants to get paid with MFO money now while it is available in case the company goes under.
If he believes his stock is worthless then recouping the million in cash he is owed would be a top priority.
Who knows what the real story is. I have never seen so much drama and oddity in a company before.
Aruda conflicts.
Paying lawyers with options.
Three wise men investors.
MFO.
Menon friend or foe.
Lease conflicts
It has been a bloody circus. Get a deal signed and bring us back to a reputable state Leo!"
Don't forget hiring a cro stacked with family members from both company officers and giving shares away to family and friends(anyone think those give away's are still within any of those recipients possession?
jazz started around the same time as ipix/ctix. The big difference is jazz first reported positive earnings in August 2009 of .07 , followed by an eps of -.05 in Nov 2009 and has never looked back.
“(e) Forced Exercise. Subject to the provisions of this Section 2(e), if and only if (i) a registration statement shall be effective as to all of the Warrant Shares and the prospectus thereunder available for use by the Company for the sale of all such Warrant Shares to the Holder for the last thirty (30) days, (ii) the Common Stock shall be listed or quoted for trading on the Trading Market for the last thirty (30) days, (iii) there is a sufficient number of authorized shares of Common Stock for issuance of all of the Conversion Shares under the Preferred Stock then outstanding and issuable upon exercise in full of this Warrant and there is no existing Authorized Share Failure for the last thirty (30) days, (iv) there is no Triggering Event or any event that has occurred and, with passage of time or delivery of notice, would result in a Triggering Event for the last thirty (30) days, (v) there has been no public announcement of a pending or proposed Fundamental Transaction or Change of Control Transaction that has not been consummated, (vi) the Holder is not in possession of any information that constitutes, or might constitute, material non-public information which was provided by the Company, any of its Subsidiaries, or any of their officers, directors, employees, agents or Affiliates, (vii) the Holder has not been subject to any restriction or limitation on conversions of shares of Preferred Stock or trading in general from Holder’s prime broker which restricts at all the Holder’s conversions of shares of Preferred Stock then held by the Holder or conversions of any Warrant Shares for the last thirty (30) days, (viii) the average daily trading volume of the Common Stock on the principal Trading Market for the 30 Trading Days immediately prior to a Forced Exercise is not less than $40,000 and (ix) each VWAP for the Common Stock for the 30 Trading Days immediately prior to a Forced Exercise has not, at any time during such period, been less than $0.05, subject to adjustment for reverse and forward stock splits and the like, then the Company shall have the right to require the Holder to exercise a portion of this Warrant equal to up to $400,000 of aggregate Exercise Price into Warrant Shares (a “Forced Exercise”) per calendar month commencing on June 3, 2019 and on the first Trading Day of each month thereafter until the earlier of such time that the aggregate amount of Forced Exercises is $2,000,000 and November 1, 2019 (each such date, the “Forced Exercise Date”), which $400,000 and $2,000,000 respectively, of aggregate Exercise Price shall be allocated pro-rata among the Holders of the Warrants based on such Holder’s original Subscription Amount, provided that, in connection with any Forced Exercise, the Holder shall have the right to exercise Series 1 Warrants, Series 2 Warrants, and/or Series 3 Warrants held by such Holder in such Holder’s sole discretion in the amount of the Forced Exercise; provided, however, that in no event shall a Forced Exercise occur on any date on which there is not an effective registration statement for the issuance of all of the Warrant Shares and the prospectus thereunder available for use by the Company for the sale of all such Warrant Shares to the Holder or on any date on which there is an Authorized Share Failure; provided, further however, that, if the Holder exercises any portion of this Warrant at any time on or prior to a Forced Exercise Date, the Company’s right to require the Holder to exercise a portion of this Warrant shall be reduced, on a $1 for $1 basis (based on aggregate Exercise Price of any exercises on or prior to the Forced Exercise Date), which shall reduce the aggregate Exercise Price subject to the next Forced Exercise hereunder. The Company may exercise its right to require a Forced Exercise under this Section 2(e) by delivering a written notice thereof to all, but not less than all, of the holders of Warrants issued under the Purchase Agreement (such notice, a “Forced Exercise Notice” and the date thereof, a “Forced Exercise Notice Date”) at least ten (10) Trading Days prior to the Forced Exercise Date. For purposes of this Section 2(e), “Forced Exercise Date” shall be deemed to replace the date of delivery of the Notice of Exercise for all purposes hereunder as if the Holder delivered an Exercise Notice to the Company on the Forced Exercise Date. For the avoidance of doubt, if (i) any Authorized Share Failure or any Triggering Event has occurred and is continuing, unless such Triggering Event has been waived in writing by the Holder, the Company shall have no right to effect a Forced Exercise, provided that such Triggering Event shall have no effect upon the Holder’s right to exercise this Warrant in its discretion, and (ii) the Company may deliver a Forced Exercise Notice on the Forced Exercise Notice Date even though certain conditions to the Forced Exercise may only be satisfied on the Forced Exercise Date, provided that the Forced Exercise shall remain contingent upon the satisfaction of such conditions on the Forced Exercise Date. If the Company elects to cause a Forced Exercise of this Warrant pursuant to this Section 2(e), then the Company must simultaneously take the same action in the same proportion with respect to up to $400,000 of aggregate Exercise Price of the Warrants issued under the Purchase Agreement.”
2
3. Issuance of Additional Securities. In consideration for the covenants and amendments set forth in Section 1 and 2 of this Agreement, the Company hereby agrees to issue to the Purchasers, for no additional consideration, (a) on the date hereof, New Warrants, in the form of Exhibit A attached hereto, to purchase up to 2,500 shares of Series B Preferred, issued pro rata to the Purchasers based on initial Subscription Amounts under the Purchase Agreement, and (b) on the date hereof, 100 shares of Series B Preferred with the rights and preferences set forth in the Amended Certificate of Designation of the Series B Preferred that has been filed with the Secretary of State of Nevada in the form of Exhibit B attached hereto (the “Amended Certificate of Designation”), issued pro rata to the Purchasers based on the aggregate Exercise Price of the Warrants exercised pursuant to Section 1. The Company shall promptly deliver to the Purchasers the Additional Securities under clauses (a) and (b) herein within 2 Trading Days of the date hereof. In addition, during the period commencing on the date hereof and ending on November 9, 2019, upon each exercise of the New Warrants and/or the Warrants (in any combination thereof) by the Purchasers, the Company shall issue to the exercising Purchaser a number of shares of Series B Preferred equal to one (1) share of Series B Preferred for each five (5) shares of Series B Preferred issued upon such exercise of the New Warrants or the Warrants, as applicable, up to an aggregate of 400 shares of Series B Preferred for the exercise of the New Warrants issued pursuant to clause (a) herein and/or the exercise of the Warrants (in any combination thereof), which shares of Series B Preferred shall be delivered to the respective Purchaser on the Warrant Share Delivery Date (as defined in the New Warrants or the Warrants, as applicable) related to such exercise of the New Warrants and/or the Warrants.
4. Extension of Warrant Termination Dates. The Termination Dates of the Series 1 Warrants shall be extended by six (6) months. Each Purchaser may require the Company to provide such Purchaser with new Series 1 Warrant certificates reflecting the amended terms under this Agreement, in form satisfactory to such Purchaser.
5. Amendment to Purchase Agreement. The Company and the Purchasers hereby agree to amend the definition of “Required Minimum” in Section 1.1 of the Purchase Agreement by inserting at the end of the definition of “Required Minimum” as follows:
“; provided, however, that, for the period of one hundred eighty (180) days following May 9, 2019 only, the Required Minimum shall be fixed at 70 million shares of Common Stock (subject to adjustment for forward and reverse stock splits, recapitalizations and similar transactions), provided further, however, that, following the expiration of such period, the Required Minimum shall equal the number of shares of Common Stock required hereunder.”
Don't forget your life preserver.
I'm sure most of the ehrlichs sold their free shares LONG ago.
"Go LW, go BDD, go Leo, go B, go K, GO GO GO IPIX..."
I think they're all gone(must admit- I can't prove the first two actually had/have an agreement or contract with "the company").
I'm beginning to wonder if number three on the list has "flown the coop" so to speak. Probably rented a desk for an hour and did go.
I guess the JP Morgan conference is not so top secret as presented by some here.
https://investors.revance.com/news-releases/news-release-details/revance-participate-38th-annual-jp-morgan-healthcare-conference
https://investors.revance.com/static-files/59239ad6-3694-4d7e-b245-409cb9314814
"One could make the argument that both Tesla and Innovation Pharma address Billion dollar markets with their products."
Tesla has proven they are more than a billion dollar market.
https://www.theverge.com/2020/1/29/21113987/tesla-q4-2019-earnings-results-profit-revenue-model-3
"Let's see what Locust Walk can put together, for starters, and
The B-UC oral results are coming any day now."
We'll have to continue to wait and see.
What Tesla has accomplished in the 10 years since going public is incomparable to ipix's progress.
"February is off to a good start for Tesla CEO Elon Musk.
Short-sellers entered a new world of pain on Monday as shares surged more than 19 percent, eclipsing $700 for the first time following a slew of positive commentary from Wall Street. The percentage gain was the largest since May 2013, as tracked by the Dow Jones Market Data Group and a fresh all-time high.
Short-sellers, or traders betting against a stock in the hope that its price will fall, were saddled with $2.47 billion of losses on Monday when shares were trading at $752, according to the financial-analytics firm S3 Partners. They have now lost more than $8.3 billion this year.
That pain may increase as the stock approaches the $800 level."
Interesting. I trust you are not comparing Tesla to ipix, nor Elon Musk to the ipix ceo.
Tesla trades at nearly 10,000 times the ipix sp, has capable and deep management, an actual office with working phones.
Yesterday the sp opened at the high of h day(.085) and closed at the low(.072). The last time it opened at the high and closed at the low was 10/17/19(Hi .11, low .095). It spiraled down to .053 on 12/5/19 and made its highest close yesterday(.085).
The sp also opened on a high and closed on a low on 9/24/19(hi .13.low .1188) and 8/8/19 (hi .15, low .135).
Only went back six months, but each time the sp has opened on its hod and closes on the lod the trend has been downward.
"Great News ! Phase 1 Dosing complete!! This will open the door to Big Deals from Big Pharma !!
GO IPIX !!!"
Hopefully it serves investors better than both the completion of the ph 1 and ph 2 of K.
Phase 1- enough said- why didn't they advise what that p 1 study is specifically targeting?
I do know the answer to my question, but do new eyes know the ultimate goal?
"If the stars line up we can both quit our day jobs. Go IPIX, LW and especially B. Bring the Great trial results B and all the nonsense ends."
HA-HA, "If the stars line up".... . More like if the ceo SHOWS UP. How often is he in Wakefield (be forewarned,tis a rhetorical question on my part).
Those were the days.
"Every time I see this info from Locust Walk’s website, I get that to thinking I made a good choice in doubling down on my share count and buying what I can when I can...."
Your sentiment has been shared by others for years. As the sp now delves in the bowels of most legitimate stocks, I wish you you good luck on additional outlays, if that is what you decide. To new comers, be vwry, vwrey careful. Twould't trust him as I could throw him.
Posted by a non numbers guy. Only off by a year-stop questioning.
Phase 1 is equivalent to teaching a hurdler stride and timing using tennis balls as hurdles.
The coach measures the speed of the runner, assesses the coordination, timing, and form of the runner to determine if he/she may make a good hurdler.
Advance to low hurdles if one does well then, perhaps, high hurdles.
No kidding. What, do you reckon, is a reasonable(unconcerning) short sale limit as far as a long investor is concerned, and how does it compare to what the resident expert(not referring to you- my apologies if you are) deems appropriate?
Today's pr?
I didn't notice an address or telephone number on the info provided by Ameritrade, This was the info provided by the pr them (ameritrade): INVESTOR AND MEDIA CONTACT
Innovation Pharmaceuticals Inc.
Leo Ehrlich
info@ipharminc.com
Thanks for the effort. Are you sure you remember what he looks like?
If not, you should be able to find a current photo at any P.O poster board.
Did he slip on his own ****?
Call the ceo. I believe he knows Karl Malden, who could help you navigate the streets of San Francisco. Good luck, you've a better chance of the latter rising from the dead than the former picking up the phone.
Follow the bouncing ball?
That's how the cookie crumbles?
Swing and a miss?
Almost!
Where are we now, and who, and how, can anyone contact the leader(s) of this company(ipix)?
He implied that item 1.01 of 8-k was gray.
He did say they would have to file under item 2 of the 8-k.
Well, I was planning to attend the next shareholder's meeting. To quote an Warner Brothers cartoon- which way to I go George, which way do I go?
p.s Appreciate your response.
Anyone curious as to why the ceo/investor relations point person hasn't informed shareholders of the office move to Wakefield, MA.
All other public companies that I'm familiar with that have relocated notify sh's via pr followed by an 8k.
Wouldn't they have to sign some sort lease agreement for the new space? Wouldn't that fall under Entry into a Material Definitive Agreement per item 1.01 of form 8k?
"Only moments ago I got off the phone with the Queen of England who told me that she just broke up with Jamie Dimon because he lied when he said that it was HE who is the CEO of JP Morgan. Boy was she pissed!"
Oh, that doesn't surprise me.I spoke with dizzy Lizzy and Jamie earlier in the week on a conference about this very issue. Prince Philip has forgiven her, but Megan and Harry have, evidently, had enough particularly given "Uncle Andy's"(Prince Andrew) alleged behavior.
"plus I did speak to David ke which is the ceo of J.P. Morgan gave him a off record info
On iPix"
How long ago did you speak with him?
"LE doesn't have the time nor years of experience they have to move things along and cut a fair deal."
He possesses plenty of time but lacks any experience to move things along, imho. He's doing something, but nothing beneficial for ipix shareholders imho.
"I just hope he sells the drugs or the company as vigorously as he is selling shares."
Do you suspect he's selling shares w/o filing form 4's, or are you referring to dilution via the mfo?
"Leo is limping into negotiations...."
Though I do appreciate your enthusiasm, I think it more likely that he's talking to himself on a park bench and occasionally with the pigeons as he tries to convince them to give him their bread crumbs.
Remember the grand ole days of 9/2016 when the sp was sky high at ~1.31 . When some questioned whether either MM wanting to sell a few shares up a bit or maybe something is going on?
Do you remember Peg, oh, those were the days(a little Al Bundy take)!
Oh yeah, they(he) are (is) not looking for fda approval I guess. Should have approval in New York minute since it's being conducted in the U.K!
https://www.sciencedirect.com/science/article/pii/S2452302X16300638
He seas and decerns better than many here.